Literature DB >> 9725819

Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone.

C D Russell1, R N Petersen, S P Rao, M R Ricci, A Prasad, Y Zhang, R E Brolin, S K Fried.   

Abstract

We investigated the in vitro regulation of leptin expression in adipose tissue from severely obese women and men before and after culture with insulin (7 nM) and/or dexamethasone (25 nM). Leptin mRNA and leptin secretion were two- to threefold higher in subcutaneous vs. omental adipose tissue before culture. Dexamethasone transiently increased leptin mRNA approximately twofold in both depots after 1 day of culture [P < 0.01 vs. basal (no hormone control)], but leptin secretion was only increased in omental adipose tissue (P < 0.005 vs. basal). Insulin did not increase leptin mRNA in either depot but increased leptin secretion approximately 1.5- to 3-fold in subcutaneous tissue throughout 7 days of culture (P < 0.05 vs. basal). The combination of insulin and dexamethasone increased leptin mRNA and leptin secretion approximately two- to threefold in both depots at day 1 (P < 0.005 vs. basal or insulin) and maintained leptin expression throughout 7 days of culture. We conclude that insulin and glucocorticoid have depot-specific effects and function synergistically as long-term regulators of leptin expression in omental and subcutaneous adipose tissue from obese subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725819     DOI: 10.1152/ajpendo.1998.275.3.E507

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  41 in total

1.  Effect of one morning meal and a bolus of dexamethasone on 24-hour variation of serum leptin levels in humans.

Authors:  B Laferrère; S K Fried; T Osborne; F X Pi-Sunyer
Journal:  Obes Res       Date:  2000-10

Review 2.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 3.  Obesity and adipokines: effects on sympathetic overactivity.

Authors:  Michael M Smith; Christopher T Minson
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

4.  Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study.

Authors:  Mi-Jeong Lee; Da-Wei Gong; Bryan F Burkey; Susan K Fried
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

Review 5.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

6.  Specific increase in leptin production in obese (falfa) rat adipose cells.

Authors:  Sophie Turban; Isabelle Hainault; Johan Truccolo; Jocelyne Andre; Pascal Ferre; Annie Quignard-Boulange; Michèle Guerre-Millo
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

7.  Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

Authors:  Susan A Phillips; Theodore P Ciaraldi; Deborah K Oh; Michelle K Savu; Robert R Henry
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

8.  Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.

Authors:  Mi-Jeong Lee; Susan K Fried; Steven S Mundt; Yanxin Wang; Sean Sullivan; Alice Stefanni; Bruce L Daugherty; Anne Hermanowski-Vosatka
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

9.  Inhibiting endogenous cortisol blunts the meal-entrained rise in serum leptin.

Authors:  Blandine Laferrère; Cynthia Abraham; Marianne Awad; Stephanie Jean-Baptiste; Allison B Hart; Pilar Garcia-Lorda; Peter Kokkoris; Colleen D Russell
Journal:  J Clin Endocrinol Metab       Date:  2006-03-14       Impact factor: 5.958

Review 10.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.